Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile2 entries
2023
Access suspensions and governance criticism
Researchers criticized GISAID after some accounts were suspended and data relevant to SARS-CoV-2 origin investigations temporarily became inaccessible. Critics also questioned the transparency and consistency of the platform's governance and access rules.
2009
EpiFlu database contract dispute
The Swiss Institute of Bioinformatics disconnected the database from the GISAID portal after a contract dispute, resulting in litigation.